In long-term follow-up studies of adults previously treated during childhood with human pituitary GH, the risk of dying from cancer (specifically, colorectal cancer and Hodgkin disease) was increased in 1 UK study of 1848 patients (22) but not in a US study of 6107 patients (23). Here, GH1 is linked to Hodgkins lymphoma.